Literature DB >> 2992147

Small-cell carcinoma of prostate. Transient complete remission with chemotherapy.

D A Hindson, L L Knight, J M Ocker.   

Abstract

A patient with small-cell carcinoma of the prostate is described. The patient's clinical course and the tumor's pattern of metastases were similar to those seen in small-cell carcinoma of the lung. There was a complete, though brief, remission on chemotherapy with cyclophosphamide, doxorubicin hydrochloride (Adriamycin), and vincristine.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2992147     DOI： 10.1016/0090-4295(85)90060-3

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  10 in total

1.  Case report: subcutaneous metastasis from small cell carcinoma of the prostate.

Authors:  Mustafa Kaplan; Irfan H Atakan; Selcuk Bilgi; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Neuroendocrine carcinoma of the prostate gland.

Authors:  Pamela Hoof; Ginger Tsai-Nguyen; Scott Paulson; Almas Syed; Adam Mora
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

3.  ERG gene rearrangements are common in prostatic small cell carcinomas.

Authors:  Tamara L Lotan; Nilesh S Gupta; Wenle Wang; Antoun Toubaji; Michael C Haffner; Alcides Chaux; Jessica L Hicks; Alan K Meeker; Charles J Bieberich; Angelo M De Marzo; Jonathan I Epstein; George J Netto
Journal:  Mod Pathol       Date:  2011-02-18       Impact factor: 7.842

4.  Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.

Authors:  Hsueh-Li Tan; Akshay Sood; Hameed A Rahimi; Wenle Wang; Nilesh Gupta; Jessica Hicks; Stacy Mosier; Christopher D Gocke; Jonathan I Epstein; George J Netto; Wennuan Liu; William B Isaacs; Angelo M De Marzo; Tamara L Lotan
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

5.  Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin.

Authors:  S Naito; T Ueda; S Kotoh; J Kumazawa; K Itoh; K Sagiyama; T Omoto; S Andoh; Y Hasegawa; Y Fujisawa
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Small cell carcinoma of the prostate.

Authors:  Rosa Nadal; Michael Schweizer; Oleksandr N Kryvenko; Jonathan I Epstein; Mario A Eisenberger
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

7.  Platinum-based chemotherapy for variant castrate-resistant prostate cancer.

Authors:  Ana M Aparicio; Andrea L Harzstark; Paul G Corn; Sijin Wen; John C Araujo; Shi-Ming Tu; Lance C Pagliaro; Jeri Kim; Randall E Millikan; Charles Ryan; Nizar M Tannir; Amado J Zurita; Paul Mathew; Wadih Arap; Patricia Troncoso; Peter F Thall; Christopher J Logothetis
Journal:  Clin Cancer Res       Date:  2013-05-06       Impact factor: 12.531

Review 8.  Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review.

Authors:  Meera Dhavale; Mohamed K Abdelaal; A B M Nasibul Alam; Tatjana Blazin; Linha M Mohammed; Dhruvil Prajapati; Natalia P Ballestas; Jihan A Mostafa
Journal:  Cureus       Date:  2021-02-17

9.  Small cell prostate carcinoma: a case report and review of the literature.

Authors:  Abdullah Demirtaş; Nurettin Sahin; Figen Oztürk; Emre Can Akınsal; Türev Demirtaş; Oguz Ekmekçioğlu; Atila Tatlışen
Journal:  Case Rep Urol       Date:  2013-02-28

10.  Extrapulmonary Small Cell Carcinoma of the Seminal Vesicles and Prostate Demonstrated on 18F-FDG Positron Emission Tomography/Computed Tomography.

Authors:  Amir Iravani Tabrizipour; Lily Shen; Robert Mansberg; Bui Chuong
Journal:  Mol Imaging Radionucl Ther       Date:  2016-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.